Melphalan 180 mg/m2 Can Be Safely Administered As Conditioning Regimen before an Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma Patients with Creatinine Clearance 60 mL/min/1.73 m2 or Lower with Use of Palifermin for Cytoprotection: Results of a Phase I Trial

✍ Scribed by Abidi, Muneer H.; Agarwal, Rishi; Ayash, Lois; Deol, Abhinav; Al-Kadhimi, Zaid; Abrams, Judith; Cronin, Simon; Ventimiglia, Marie; Lum, Lawrence; Zonder, Jeffrey; Ratanatharathorn, Voravit; Uberti, Joseph

• Book ID: 120052037
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 139 KB
• Volume: 18
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2012.03.010